Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	14.05	82.38	72.24
Graham Fair Price	46.59	26.35	17.97
PEG	-72.22	0.10	-0.35
Price/Book	10.40	1.02	0.92
Price/Cash Flow	134.01	-19.24	8.22
Prices/Earnings	-47.65	11.20	21.39
Price/Sales	-10.24	11.58	12.90
Price/FCF	134.01	-19.24	8.22
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-52.61	0.47	1.00
Operating Margin	87.77	0.28	0.15
ROA	106.20	< 0.005	< 0.005
ROE	0.01	0.02	110.90
ROIC	< 0.005	< 0.005	40.42
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.99	0.01	8624.09
Dividends QOQ	-0.07	0.13	85.46
EBIT QOQ	-0.61	1.32	115.70
EPS QOQ	-0.60	1.14	88.43
FCF QOQ	1.78	-1.47	-17.13
Revenue QOQ	-0.13	0.24	85.04
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	-2744.82	-100.00
Days Sales Outstanding (DSO)	417.30	351.56	-15.75
Inventory Turnover	0.00	-0.03	-100.00
Debt/Capitalization	0.53	0.69	29.89
Quick Ratio	0.74	0.72	-2.38
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	36.50	36.84	0.94
Cash	76.10	79.61	4.62
Capex	0.00	0.00	0.00
Free Cash Flow	4.10	-1.95	-52.38
Revenue	2.61	3.24	24.15
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.02	1.02	-0.64
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-1.96	44.06	2144.58
Naive Interpretation	Member

06 - Financial Health · Bad

Rating